June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Iron Upregulates Melanogenesis Genes in the RPE
Author Affiliations & Notes
  • Natalie Wolkow
    Scheie Eye Institute, The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
  • Arvydas Maminishkis
    National Eye Institute, National Institutes of Health, Bethesda, MD
  • Jared Iacovelli
    Schepens Eye Research Institute, Harvard Medical School, Boston, MA
  • Jennifer Lee
    Pennsylvania College of Optometry, Salus University, Elkins Park, PA
  • Sheldon Miller
    National Eye Institute, National Institutes of Health, Bethesda, MD
  • Joshua Dunaief
    Scheie Eye Institute, The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
  • Footnotes
    Commercial Relationships Natalie Wolkow, None; Arvydas Maminishkis, None; Jared Iacovelli, None; Jennifer Lee, None; Sheldon Miller, None; Joshua Dunaief, ApoPharma, Inc. (F), ApoPharma, Inc. (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6071. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Natalie Wolkow, Arvydas Maminishkis, Jared Iacovelli, Jennifer Lee, Sheldon Miller, Joshua Dunaief; Iron Upregulates Melanogenesis Genes in the RPE. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6071.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The purpose of our study was to examine the effects of iron on melanogenesis in human fetal RPE cells. Our prior studies on retinas from mice and humans with altered iron transport suggested that increased iron may influence the cellular pathways used for melanosome biogenesis and degradation in RPE cells.

Methods: Human Fetal RPE cells were treated with 250µM ferric ammonium citrate for one week. RNA was extracted using the QIAGEN RNeasy Mini Kit. Reverse transcription and quantitative PCR were performed using Taqman reagents and Taqman probes.

Results: Human fetal RPE cells that were treated with ferric ammonium citrate for 1 week had significantly increased RNA expression levels of Tyrosinase (1.5-fold, p<0.05), Tyrosinase-related protein 1 (1.5-fold, p<0.05) and Hermansky-Pudlak Syndrome 3 (1.4-fold, p<0.01) genes; however, the RNA expression level of the melanosome structural protein, Premelanosome protein (PMEL), was not increased. Additionally, the RNA expression level of Microphthalmia associated transcription factor (MITF), which is an upstream regulator of all the aforementioned genes, was upregulated 1.6-fold (p<0.001). Several pathways converge on MITF to cause MITF upregulation. Of the known regulators of MITF expression, SRY-box 9 (Sox 9) and SRY-box 10 (Sox 10) RNA expression levels were upregulated after iron treatment, Sox 9 was upregulated 1.6-fold (p<0.05) and Sox 10 was upregulated 1.4-fold (p<0.01).

Conclusions: Human fetal RPE cells upregulate several genes that are important for melanogenesis after exposure to ferric ammonium citrate. The upregulation of these melanogenesis genes likely occurs via the Sox 9 and Sox 10 pathways of MITF activation. Since melanosomes can bind iron and, up to a point, protect cells from its deleterious effects, iron-induced melanogenesis may be cytoprotective.

Keywords: 701 retinal pigment epithelium • 694 retinal culture  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×